Allianz's Capital Engine Runs on Two Cylinders: Buybacks and a Portuguese Bolt-On

Allianz continues €2.5B buyback, acquires Caravela for €150M, and sees analyst target hikes despite board reshuffle.

The insurance giant's strategy this summer reads less like a single grand gesture and more like a steady drumbeat of incremental moves. On one front, Allianz continues to grind through its share repurchase program with mechanical precision, having now retired more than five million of its own shares since March. On the other, it has quietly sealed a €150 million deal to take full control of Portuguese insurer Caravela, a bolt-on acquisition that nudges its market share in the country to 6.4 percent.

The latest buyback tranche, completed between August 10 and 14, saw the company acquire 215,946 shares at an average price of €438.70. That brings the cumulative tally since the program's March start to 5,149,477 shares. The purchases are being executed in weekly installments, a cadence the company has maintained without interruption even as the stock hovers near record territory.

That persistence is worth noting. The closing price on Wednesday stood at €437.80, marginally below the average cost of the most recent tranche, and the shares have recently touched a 52-week high of €443.80. Rather than pausing to wait for a pullback, management is signaling that it views the current valuation as no obstacle to returning excess capital to shareholders. The approach stands in contrast to the opportunistic buybacks some companies deploy only when shares are under pressure.

The broader picture is one of capital being deployed in two directions at once. The buyback program, budgeted at €2.5 billion for the full year, had already consumed €1.4 billion by the end of the first half. That cash return is underpinned by a Solvency II ratio of 225 percent at mid-year, up seven percentage points from the end of 2025. The Caravela acquisition, meanwhile, represents a comparatively modest outlay aimed at densifying Allianz's footprint in Southern Europe, a market where it has historically held a smaller presence.

The timing of these moves coincides with a flurry of analyst activity. Goldman Sachs lifted its price target on Allianz from €450 to €465 on Wednesday, reaffirming a "Buy" rating, while JPMorgan raised its target from €430 to €460 but held the stock at "Neutral." Both houses cited the strong first-half operating performance and record inflows at the asset management division, which encompasses Pimco and Allianz Global Investors, as justification for the revisions.

There is also a governance dimension to the summer's developments. Günther Thallinger will step down from the board at year-end, a change announced on July 24. His responsibilities for global health insurance, investment management, and sustainability will be split between Tomas Kunzmann and Andreas Wimmer, reducing the board's size from nine to eight members. The reshuffle comes on the heels of the half-year results, released the previous Friday, after which the stock has eased roughly 0.9 percent — a muted reaction given the shares remain just 1.3 percent below their August 6 high.

The competitive backdrop adds another layer. Munich Re confirmed on Thursday the completion of its $575 million acquisition of US insurtech At-Bay, underscoring that Europe's major insurers are simultaneously pursuing both external deals and share buybacks as they convert capital strength into strategic optionality.

For investors, the individual pieces — a modest Portuguese acquisition, a streamlined board, another weekly buyback tranche — are less significant than the pattern they form. The company is returning capital, expanding selectively, and maintaining operational momentum all at once. The next test comes with third-quarter results on November 12, which should offer early signals on how smoothly Caravela integrates and whether the new board structure translates into executional continuity.